CervoMed Inc. – Filings and Transcripts

NASDAQ: CRVO
Share price (4/23/26): $3.85
Market cap (4/23/26): $35.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement

Prospectus supplement

Ownership Filter

AWM Investment Company, Inc.

Gregoire Sylvie

Elder William Robert

News Filter

Announces New Data at the 2026 AAN Annual Meeting That Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia With Lewy Bodies

To Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting

Material Disclosure, Financial Statements or Exhibits

Announces New Data at the AD/PD™ 2026 Scientific Conference That Reinforce Neflamapimod’s Positive Effects in Dementia With Lewy Bodies (DLB) in Patients Without Alzheimer’s Disease Co-Pathology

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Revised preliminary proxy by non-management

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness